Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06273592Not ApplicableRecruiting

The Impact of a Plant-based Meat Meal Versus an Animal Meat Meal on Erectile Function in Healthy Men.

Role: collaborator

NCT06082817Phase 2Not Yet Recruiting

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

Role: lead

NCT06600893Not ApplicableCompleted

Sham-Controlled Prospective Study Characterizing Erectile Tissue Ultrasound Changes Resulting From Penile LiSWT

Role: lead

NCT03877640Not ApplicableUnknown

Urinary Stress Incontinence and Urgency in Women With EMSELLA

Role: lead

NCT02714049Phase 4Terminated

Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy

Role: lead

NCT03568604Phase 4Completed

Changes to Vulva, Vestibule, Urethral Meatus and Vagina 20 Weeks Post Daily Prasterone in Women With Dyspareunia

Role: lead

All 6 trials loaded